n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and Arthritis, Psoriatic

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with Arthritis, Psoriatic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caso, F; Chimenti, MS; Conigliaro, P; Costa, L; De Martino, E; Fonti, GL; Perricone, C; Perricone, R; Sunzini, F; Triggianese, P	1
Warren, RB; Yiu, ZZ	1

Reviews

2 review(s) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and Arthritis, Psoriatic

Article	Year
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets. Expert review of clinical immunology, 2019, Volume: 15, Issue:8 Topics: Abatacept; Adenosine; Alleles; Arthritis, Psoriatic; Genetic Predisposition to Disease; HLA Antigens; Humans; Immunoglobulins; Immunosuppressive Agents; Treatment Outcome	2019
Novel Oral Therapies for Psoriasis and Psoriatic Arthritis. American journal of clinical dermatology, 2016, Volume: 17, Issue:3 Topics: Adamantane; Adenosine; Adenosine A3 Receptor Antagonists; Administration, Oral; Arthritis, Psoriatic; Azetidines; Biological Factors; Biological Therapy; Clinical Trials as Topic; Humans; Isonicotinic Acids; Janus Kinases; Niacinamide; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Lysosphingolipid; rho-Associated Kinases; Sulfonamides; Thalidomide; Thiazoles	2016

Article

Year

An update on pathogenesis of psoriatic arthritis and potential therapeutic targets.

Expert review of clinical immunology, 2019, Volume: 15, Issue:8

Topics: Abatacept; Adenosine; Alleles; Arthritis, Psoriatic; Genetic Predisposition to Disease; HLA Antigens; Humans; Immunoglobulins; Immunosuppressive Agents; Treatment Outcome

2019

Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.

American journal of clinical dermatology, 2016, Volume: 17, Issue:3

Topics: Adamantane; Adenosine; Adenosine A3 Receptor Antagonists; Administration, Oral; Arthritis, Psoriatic; Azetidines; Biological Factors; Biological Therapy; Clinical Trials as Topic; Humans; Isonicotinic Acids; Janus Kinases; Niacinamide; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Lysosphingolipid; rho-Associated Kinases; Sulfonamides; Thalidomide; Thiazoles

2016